UNITY Biotechnology's Series B - II Round

UNITY Biotechnology raised a round of funding on August 17, 2017.

UNITY Biotechnology, formerly Cenexys, designs therapeutics that prevent, halt, or reverse diseases of aging. The company's medicines are designed to lengthen healthspan, the amount of time people liv…

Articles about UNITY Biotechnology's Series B - II Round: